TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05204693

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: 15 minutes eccentric cycling
Description: The exposure to eccentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 15 minutes eccentric cycling
Description: The exposure to eccentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: 15 minutes concentric (normal) cycling
Description: The exposure to concentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 15 minutes concentric (normal) cycling
Description: The exposure to concentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.
Study: NCT06193109

Intervention type: OTHER
Description: the patients with sepsis and septic shock were performed echocardiography for detecting right ventricular systolic function
Study: NCT06113679

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RDX-19
Description: RD-X19 device with a 5 minute, 32 J/cm2 dose, 2X/day, 7 days. Each treatment at least 6 hours apart.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: RDX-19
Description: RD-X19 device with a 5 minute, 32 J/cm2 dose, 2X/day, 7 days. Each treatment at least 6 hours apart.
Study: NCT04599530

Intervention type: DEVICE
Group type: OTHER
Intervention: Talaris Demonstrator
Description: The Talaris Demonstrator will be evaluated during daily activities and compared to the current prosthesis

Intervention type: DEVICE
Group type: OTHER
Intervention: Talaris Demonstrator
Description: The Talaris Demonstrator will be evaluated during daily activities and compared to the current prosthesis

Intervention type: DEVICE
Group type: OTHER
Intervention: Talaris Demonstrator
Description: The Talaris Demonstrator will be evaluated during daily activities and compared to the current prosthesis

Intervention type: DEVICE
Group type: OTHER
Intervention: Talaris Demonstrator
Description: The Talaris Demonstrator will be evaluated during daily activities and compared to the current prosthesis
Study: NCT04847713

Intervention type: OTHER
Intervention: extraction of blood samples
Description: Two blood samples (3.5 ml each) will be collected directly into purple K2-EDTA tubes and stored at 4°C for up to 24 hours for analysis

Intervention type: OTHER
Intervention: extraction of blood samples
Description: Two blood samples (3.5 ml each) will be collected directly into purple K2-EDTA tubes and stored at 4°C for up to 24 hours for analysis
Study: NCT05995067

Intervention type: OTHER
Intervention: periodontitis challenge
Description: control will be compared to diseased group suffering from periodontal disease.
Study: NCT05207800

Intervention type: OTHER
Intervention: The concentrations of PTX3 and HBP were monitored in maternal blood, placental tissue and amniotic fluid.
Description: The concentrations of PTX3 and HBP were monitored in maternal blood, placental tissue and amniotic fluid.

Intervention type: OTHER
Intervention: The concentrations of PTX3 and HBP were monitored in maternal blood, placental tissue and amniotic fluid.
Description: The concentrations of PTX3 and HBP were monitored in maternal blood, placental tissue and amniotic fluid.

Intervention type: OTHER
Intervention: The concentrations of PTX3 and HBP were monitored in maternal blood, placental tissue and amniotic fluid.
Description: The concentrations of PTX3 and HBP were monitored in maternal blood, placental tissue and amniotic fluid.
Study: NCT06218498

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ablative fractional 2940-nm Er: YAG laser
Description: Ablative fractional 2940-nm Er: YAG laser (Dermablate MCL31, Asclepion Laser Technologies, Germany), the following parameters were used: model of N25%, energy density of 20-30J/cm2, pulse time of 300μs and one to two passes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: non-ablative fractional 1565nm
Description: Non-ablative fractional 1565nm (Lumenis, M22): Resur Fx len, energy of 30-35J/cm2, density of 200spot/cm2, overlap ≤10%.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5% Minoxidil
Description: topical 5% minoxidil, 1 ml, twice daily
Study: NCT05977244

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HGI+palm olein
Description: A 5-hour postprandial feeding intervention with 1-weeks washout in between. Blood samples will be collected at 0 hour (baseline) and up to 5 hours after consumption of test meal.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LGI+palm olein
Description: A 5-hour postprandial feeding intervention with 1-weeks washout in between. Blood samples will be collected at 0 hour (baseline) and up to 5 hours after consumption of test meal.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HGI+soy bean oil
Description: A 5-hour postprandial feeding intervention with 1-weeks washout in between. Blood samples will be collected at 0 hour (baseline) and up to 5 hours after consumption of test meal.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LGI+soy bean oil
Description: A 5-hour postprandial feeding intervention with 1-weeks washout in between. Blood samples will be collected at 0 hour (baseline) and up to 5 hours after consumption of test meal.
Study: NCT05331404

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: PET examination
Description: PET examinations with auditory stimuli such as human voice and environmental sounds.

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: PET examination
Description: PET examinations with auditory stimuli such as human voice and environmental sounds.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality of life assessment
Description: quality of life assessment by :~* Speech, Spatial and Qualities of Hearing~* Hearing Handicap Inventory For The Elderly Screening~* Short Form Health Survey

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality of life assessment
Description: quality of life assessment by :~* Speech, Spatial and Qualities of Hearing~* Hearing Handicap Inventory For The Elderly Screening~* Short Form Health Survey

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality of life assessment
Description: quality of life assessment by :~* Speech, Spatial and Qualities of Hearing~* Hearing Handicap Inventory For The Elderly Screening~* Short Form Health Survey
Study: NCT05070351

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PPI deprescribing
Description: Patients currently on a proton pump inhibitor (PPI) undergoing transjugular intrahepatic portosystemic shunt (TIPS) creation as part of routine clinical care will be randomized to receive instructions to stop taking their PPI.
Study: NCT06044597

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SyncAV function on
Description: CRT-D with SyncAV plus activated
Study: NCT05290571

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Modified Otago Exercise Program with music
Description: Our study attempts to establish a new home-based exercise option incorporating mOEP with video, music and lyrics. Our new approach shares the same aims with Exergames and video-supported methods - to increase the exercise motivation of elderlies, hence their physical performance. Based on the video-supported approach in one previous study, we add in the component of music therapy. Music-based exercise interventions could produce positive outcomes on both physical, such as gait, balance and fall risk and level of physical activities and psychological, including exercise adherence, perceived exertion, thus extending exercise duration. However, exact mechanisms have not been revealed and it may be limited by personal preferences on music. In our video, the music we chose is of brisk rhythm, slightly delightful melody and higher pitch, which all help to shape a cheerful and relaxing atmosphere for the elderlies.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Modified Otago Exercise Program
Description: Otago Exercise Program (OEP) was developed by Otago Medical School in New Zealand as a tailor-made home-based fall prevention program to improve the balance performance of community-dwelling elderlies over 1 year. It comprises of 3 main components: 5 lower limb strengthening, 12 balance retraining and walking exercises. In the original program, the intensity was set as moderate with up to 4 difficulty levels for strengthening and balance exercises, in terms of ankle cuff weights and number of repetitions, and level of support respectively. It also stated that the frequency was at least 3 times a week for the former two exercises and at least 2 times per week for walking exercises; while the total duration was expected to make up to an hour, including 30-minute walking exercises.
Study: NCT05887596

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient education
Description: The education given to the intervention group included preoperative preparation, operating room environment, breathing exercises, cough exercises, etc. to be performed after surgery, non-pharmacological methods related to pain management (cold application, positioning, distraction), and pharmacological methods related to pain management.
Study: NCT04944290

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brinzolamide/brimonidine ophthalmic suspension
Description: Test product

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Simbrinza 0.2%/1% Ophthalmic Suspension
Description: Reference product
Study: NCT06317545

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan Taping
Description: Mulligan taping involves the application of tape to the lateral aspect of the elbow to offload stress during movement of the extensor tendons.
Study: NCT04536103

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: Observational Study of novel MR imaging and image processing techniques that will provide reliable and fully quantitative evaluation of inflammation, chronic structural changes and vascularity in healthy patients and patients with ACL injury.

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: Observational Study of novel MR imaging and image processing techniques that will provide reliable and fully quantitative evaluation of inflammation, chronic structural changes and vascularity in healthy patients and patients with ACL injury.

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: Observational Study of novel MR imaging and image processing techniques that will provide reliable and fully quantitative evaluation of inflammation, chronic structural changes and vascularity in healthy patients and patients with ACL injury.

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: Observational Study of novel MR imaging and image processing techniques that will provide reliable and fully quantitative evaluation of inflammation, chronic structural changes and vascularity in healthy patients and patients with ACL injury.
Study: NCT05404672

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Training
Description: Progressive breathing retraining exercises for a period of 4 weeks, for 15 minutes twice daily. As patients progressed to the seated posture, the controlled pause technique (exercise) will be introduced. 4 times a day followed by a sustained period of breathing control. In addition to this Aerobic Training (cycling, treadmill) will also be practiced for 30 minutes constituting 5 days/ week. Initial training would avoid upright position. Mild-to-moderate-intensity endurance training, progressing from semi-recumbent to upright position plus strength training will be practiced.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Treatment
Description: Progressive breathing retraining exercises for a period of 4 weeks, for 15 minutes twice daily. As patients progressed to the seated posture, the controlled pause technique (exercise) will be introduced. 4 times a day followed by a sustained period of breathing control.
Study: NCT06550154

Intervention type: OTHER
Intervention: Data collection
Description: Participants were identified by reviewing electronic medical records. Medical history information of thyroid disease and associated medication were collected in both groups, as well as a history of other comorbidities such as diabetes mellitus type 2, arterial hypertension, dyslipidemia, anxiety, and depression. Cases and controls were matched by age and sex.

Intervention type: OTHER
Intervention: Data collection
Description: Participants were identified by reviewing electronic medical records. Medical history information of thyroid disease and associated medication were collected in both groups, as well as a history of other comorbidities such as diabetes mellitus type 2, arterial hypertension, dyslipidemia, anxiety, and depression. Cases and controls were matched by age and sex.
Study: NCT06548698

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: escape room
Description: Nursing students in the intervention group analyzed the breast cancer surgery case with the escape room experience.
Study: NCT05404672

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Treatment
Description: Progressive breathing retraining exercises for a period of 4 weeks, for 15 minutes twice daily. As patients progressed to the seated posture, the controlled pause technique (exercise) will be introduced. 4 times a day followed by a sustained period of breathing control.
Study: NCT04835675

Intervention type: DEVICE
Intervention: Multi-cancer early detection test
Description: Blood collection and multi-cancer early detection testing

Intervention type: DEVICE
Intervention: Multi-cancer early detection test
Description: Blood collection and multi-cancer early detection testing
Study: NCT05265403

Intervention type: DRUG
Intervention: Commercially-available energy storage and return prosthetic foot
Description: Each patient will walk in the Freedom Highlander, a commercially-available energy storage and return prosthetic foot. The foot will be sized based on the patient's foot size and weight.

Intervention type: DEVICE
Intervention: MIT-Lower Leg Trajectory Error (LLTE) customized prosthetic feet
Description: Each patient will walk in prosthetic feet designed by the researchers at MIT. These feet will be customized for the user based on their body size (ie, height, foot length) and weight.
Study: NCT03940911

Intervention type: OTHER
Group type: OTHER
Intervention: Measurement of aerobic exercise on cycloergometer
Description: The incremental effects tests will be performed in a service specialized in the exploration of the exercise (physiology or cardiology according to the centers) in a spacious and air-conditioned room, in the presence of a medical specialist. exercise and close to the resuscitation equipment.~Before the test, weight and height will be collected. Information on the conduct of the test will be given to the patient. A multi-derivation ECG recording will be detected throughout the duration of the test and followed by a physician experienced in the ECG effort.~O2 saturation by oximetry of hens will be recorded continuously. Blood pressure will be recorded at each level. The collection of expired gases in the face mask whose tightness will be verified to measure the fractions inspired and expired in O2 and CO2 (Sensor Medics Vmax229, Yorba Linda, CA, USA) and calculations VO2 max and VCO2.~Maximal power (W max) will be recorded. Patients will be encouraged during the test.

Intervention type: OTHER
Group type: OTHER
Intervention: Measurement of aerobic exercise on cycloergometer
Description: The incremental effects tests will be performed in a service specialized in the exploration of the exercise (physiology or cardiology according to the centers) in a spacious and air-conditioned room, in the presence of a medical specialist. exercise and close to the resuscitation equipment.~Before the test, weight and height will be collected. Information on the conduct of the test will be given to the patient. A multi-derivation ECG recording will be detected throughout the duration of the test and followed by a physician experienced in the ECG effort.~O2 saturation by oximetry of hens will be recorded continuously. Blood pressure will be recorded at each level. The collection of expired gases in the face mask whose tightness will be verified to measure the fractions inspired and expired in O2 and CO2 (Sensor Medics Vmax229, Yorba Linda, CA, USA) and calculations VO2 max and VCO2.~Maximal power (W max) will be recorded. Patients will be encouraged during the test.
Study: NCT05967663

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PCI-immediate complete revascularisation
Description: In patients allocated to the immediate complete revascularisation group, PCI of the culprit lesion was attempted first and followed by all other lesions deemed to be clinically significant by the operator during the index procedure.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PCI-staged complete revascularisation
Description: In the staged complete revascularisation group, only the culprit lesion was treated during the index procedure and PCI of all non-culprit lesions deemed to be clinically significant by the operator was planned at a later stage through an elective re-admission within 15-45 days after randomisation.
Study: NCT06335550

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Robotic mastectomy
Description: Robotic mastectomy with or without reconstruction
Study: NCT05019131

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Training
Description: trainings to reduce conscious bias and stress

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer support and mentorship
Description: facilitated peer and mentorship opportunities

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Leadership engagement
Description: Engaged leadership at the county and facility levels

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Embedded champions
Description: Facilitate local champions to promote intervention
Study: NCT06308705

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: InBios Strongy Detect TM IgG ELISA
Description: The InBios Strongy Detect TM IgG ELISA detects specific IgG antibodies to Strongyloides recombinant antigens NIE and SsIR in serum. It consists of an enzymatically amplified sandwich-type immunoassay. Positive and negative control samples are provided in the kit. The test will be run and interpreted according to the manufacturer's instruction. The results are expressed as OD and nOD. Clinical interpretation of the results will be done by analysis of the Receiver Operating Characteristics (ROC) curve generated using data from confirmed positive and confirmed negative samples.
Study: NCT05971576

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LM103
Description: Fresh tumor samples will be resected from enrolled patients. Autologous TILs will be extracted and reinfused to corresponding patients after ex vivo stimulation, activation and extensive expansion.
Study: NCT06315790

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Botulinum toxin A
Description: Subcutaneously injections are given unilaterally in the face at predefined injection sites.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Isotonic saline
Description: Subcutaneously injections are given unilaterally in the face at predefined injection sites.
Study: NCT05224167

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melatonin 5 MG Sublingual Tablet
Description: Melatonin 5 mg 12 hours and 2 hours prior to surgery

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydroxyzine
Description: Hydroxyzine 1mg/kg 12 hours and 2 hours prior to surgery
Study: NCT06429553

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Minimally invasive hematoma aspiration drainage combined with urokinase injection
Description: Minimally invasive hematoma aspiration drainage combined with urokinase injection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimally invasive hematoma aspiration drainage combined with urokinase injection
Description: Minimally invasive hematoma aspiration drainage combined with urokinase injection
Study: NCT05301478

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: standard of care insole
Description: standard of care diabetic insole

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3D Printed Insole - pressure based
Description: 3D Printed Insole - pressure based
Study: NCT06665113

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: taVNS real stimulation
Description: For the real stimulation group, two modified point electrodes will deliver stimulation near the auricular branch of the vagus nerve in the left concha cymba. Stimulation parameters: frequency = 20 Hz; pulse width = 500 μs; continuous stimulation for 60 seconds, followed by a 10-second off period, repeated for 30 minutes.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: taVNS sham stimulation
Description: For the sham stimulation group, two modified point electrodes will deliver stimulation to the earlobes.Stimulation parameters: frequency = 20 Hz; pulse width = 500 μs; continuous stimulation for 60 seconds, followed by a 10-second off period, repeated for 30 minutes.
Study: NCT05922449

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Thoracic Paravertebral Block
Description: Patients randomly assigned to PV group will be placed in lateral position, and punctured using the out of plane technique guided by ultrasound (Shenzhen Huasheng Navi low-frequency convex array probe). 15 ml of 0.5% ropivacaine was administered to the T4 and T7 thoracic paravertebral spaces respectively, for a total of 30 ml. After injection, the pleura of the punctured segment and adjacent segments could be obviously moved down. Upon successful puncture, the patient was transferred to the supine position. After 5, 10, and 15 minutes, the range of sensory blockage was tested at T3\~T8 to cover the surgical area.